Livingstone Sells Elevate Hospice to Legacy Hospice

Livingstone’s healthcare team advised Elevate Hospice (“Elevate” or the “Company”), a leading provider of comprehensive hospice care across Kansas and Missouri, on its sale to Legacy Hospice, a portfolio company of Bain Capital Double Impact.  Livingstone served as the exclusive financial advisor to the Company.

“When we founded Elevate, my goal was to build an organization that truly put patients and their families first during one of life’s most difficult times. I am incredibly proud of what this team has accomplished in just a few short years, and I am confident that Legacy Hospice is the right partner to carry that mission forward” said Chuck Cuda, Owner. “This transaction is a testament to the dedication of every person at Elevate, and I look forward to watching the Company continue to grow and serve even more families across the region.”

Elevate, which is based in Independence, Missouri, has built a prominent position in Kansas and Missouri where it operates three locations and delivers personalized hospice care to more than 225 patients per day. The Company combines clinical expertise with emotional and spiritual support, offering 24/7 staff availability, in-home services, respite care, and essential medical equipment to meet the full spectrum of end-of-life needs for patients and their families.

“Drawing on our deep healthcare M&A expertise and experience advising founder-owned businesses, we identified a partner aligned with Elevate’s mission, culture, and long-term vision,” commented Jim Moskal, Partner at Livingstone. “We are proud to have advised Elevate on a transaction that positions the Company for its next chapter of growth.”

“This partnership is a tremendous milestone for our team and the patients we serve,” added Jami Degrave, Director of Operations at Elevate. “Joining Legacy Hospice accelerates our growth trajectory and gives us the scale and resources to raise the bar on hospice care across the country. We look forward to combining our clinical strengths and compassionate approach with Legacy’s platform to become a leading provider of hospice services nationwide.”

Legacy Hospice, which was acquired by Bain Double Impact in November 2025, is a leading provider of hospice services across five states in the Southeast with a specialized focus on in-home care in rural markets.

“Hospice and home-based care remain among the most active and compelling sectors in healthcare M&A, and this transaction further reinforces Livingstone’s position as a trusted M&A advisor in the sector,” said said Joe Ens, Vice President at Livingstone.

The sell-side transaction for Elevate marks Livingstone’s 21st healthcare M&A transaction in the U.S. since 2023.  These transactions, representing an aggregate enterprise value of $2.4 billion, span Livingstone’s core healthcare verticals, including senior care (home health and hospice), physical therapy, physician practice management, dental, behavioral health, and outsourced healthcare services.